Quang phổ kiểu hình điển hình của hội chứng velocardiofacial xảy ra độc lập với kích thước cụm mất đoạn trên nhiễm sắc thể 22q11.2

Scambler PJ (2000) The 22q11 deletion syndromes. Hum Mol Genet 9:2421–2426 McDonald-McGinn DM, Larossa D, Goldmuntz E et al (1997) The 22q11.2 deletion: screening, diagnostic workup, and outcome of results: report on 181 patients. Genet Test 1:99–108 Shprintzen RJ (2000) Velo-cardio-facial syndrome: a distinctive behavioral phenotype. Ment Retard Dev Disabil Res Rev 6:142–147 Digilio MC, Angioni A, De Santis M et al (2003) Spectrum of clinical variability in familial deletion 22q11.2 from full manifestation to extremely mild clinical anomalies. Clin Genet 63:308–313 Sandrin-Garcia P, Macedo C, Martelli LR et al (2002) Recurrent 22q11.2 deletion in a sibship suggestive of parental germline mosaicism in velocardiofacial syndrome. Clin Genet 61:380–383 Adeyinca A, Stockero KJ, Flynn HC et al (2004) Familial 22q11.2 deletions in DiGeorge/velocardiofacial syndrome are predominantly smaller than the commonly observed 3Mb. Genet Med 6:517–520 Morrow B, Goldberg R, Carlson C et al (1995) Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome. Am J Hum Genet 56:1391–1403 Carlson C, Papolos D, Pandita RK et al (1997) Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders. Am J Hum Genet 60:851–859 Carlson C, Sirotikin H, Pandita R et al (1997) Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am J Hum Genet 61:620–629 Edelman L, Pandita RK, Morrow BE (1999) Low-copy repeats mediate the common 3 Mb deletion in patients with velocardiofacial syndrome. Am J Hum Genet 60:1076–1086 Shaikh TH, Kurahashi H, Saitta SC et al (2000) Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet 9:489–501 Shprintzen RJ, Goldberg R, Lewin ML et al (1978) A new syndrome involving cleft palate, cardiac anomalies, typical face, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J 15:56–62 Emanuel BS, McDonald-McGinn D, Saitta SC et al (2001) The 22q11.2 deletion syndrome. Adv Pediatr 48:39–73 Shprintzen RJ, Goldberg R, Young D et al (1981) The velo-cardio-facial syndrome: a clinical and genetics analysis. Pediatrics 67:167–172 Lipson HA, Yuille D, Angel M et al (1991) Velocardiofacial (Shprintzen) syndrome: an important syndrome for the dysmorphologist to recognize. J Med Genet 28:596–604 Sandrin-Garcia P, Richieri-Costa A, Tajara EH et al (2007) Fluorescence in situ hybridization (FISH) screening for the 22q11.2 deletion in patients with clinical features of velocardiofacial syndrome but without cardiac anomalies. Genet Mol Biol 30:21–24 Sugama S, Namihira T, Matsuoka R et al (1999) Psychiatric in patients and chromosome deletions within 22q11.2. J Neurol Neurosurg Psychiatry 67:803–806 McDonald-McGinn DM, Kirschner R, Goldmuntz E et al (1999) The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns 10:11–24 McDonald-McGinn DM, Tonnessen MK, Laufer-Cahana A et al (2001) Phenotype of 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net! Genet Med 31:23–29 Ryan AK, Goodship JA, Wilson DI et al (1997) Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 34:798–804 Demczuk S, Levy A, Aubry M et al (1995) Excess of deletions of maternal origin in the DiGeorge/velo-cardio-facial syndromes: a study of 22 new patients and review of the literature. Hum Genet 96:9–13 Saitta SC, Driscoll DA, Rappaport EF et al (2000) The 22q11.2 deletion: parental origin and meiotic mechanism. Am J Hum Genet 67:163S Vogels A, Fryns JP (2002) The velocardiofacial syndrome: a review. Genet Couns 13:105–113 Gottlieb S, Emanuel BS, Driscoll DA et al (1997) The DiGeorge syndrome minimal critical region contains a goosecoid-like (GSCL) homeobox gene that is expressed early in human development. Am J Hum Genet 60:1194–1201 Pizutti A, Novelli G, Ratti A et al (1997) UFD1L, a developmentally expressed ubiquitination gene, is deleted in CATCH 22 syndrome. Hum Mol Genet 6:259–265 Yamagishi H, Garg V, Matsuoka R et al (1999) A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. Science 283:1158–1161 Halford S, Wilson D, Daw S et al (1993) Isolation of a gene expressed during early embryogenesis from the region of 22q11 commonly deleted in DiGeorge syndrome. Hum Mol Genet 2:1577–1582 Merscher S, Funke B, Epstein JA et al (2001) TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104:619–629 Liao J, Kochilas L, Nowotschin S et al (2004) Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage. Hum Mol Genet 13:1577–1585 Paylor R, Glaser B, Mupo A et al (2006) Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Nat Acad Sci 103:7729–7734 Dunham I, Collins J, Wadey R et al (1992) Possible role for COMT in psychosis associated with velo-cardio-facial syndrome. Lancet 340:1361–1362 Baker K, Baldeweg T, Sivagnanasundaram S et al (2005) COMT val108/158met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome. Biol Psychiat 58:23–31